Semih BOLU, Recep ERÖZ, Mehmet TEKİN, Mustafa DOĞAN

Atypical presentation in patients with 17 α-hydroxylase deficiency caused by a deletion in the CYP17A1 gene: short stature

Background. Patients with 17α-hydroxylase deficiency (17 OHD) usually present with tall stature and eunuchoid features, rather than growth retardation. However, unlike the classic form of the disease, short stature due to a lack of pubertal growth spurt and sex hormone deficiency was present in our four cases. We wanted to emphasize that short stature might be the cause of first presentation in patients with 17 OHD. Cases. We report five patients of Kurdish origin with 17 OHD, four of whom had short stature; two presented because of short stature and two were detected as having short stature. The external genitalia had a female appearance and was prepubertal in all cases. Hypertension was also detected in four of the patients. Serum biochemical and hormonal analyses were performed for each patient. Laboratory data suggesting severe growth hormone (GH) deficiency were obtained from one patient, while the other had a familial history suggesting constitutional delay of growth and puberty (CDGP). Whole exome sequence analysis of the CYP17A1 gene was performed on all patients. STR fragment analysis and multiplex ligation dependent probe amplification (MLPA) analysis was also performed to detect mutations associated with congenital adrenal hyperplasia (CAH) in the CYP17A1 gene. No mutation was detected in the whole exome sequence analysis of the CYP17A1 gene in all five patients, although wide deletions were identified in the 1st–6th exons of this gene at MLPA analysis. Conclusions. Patients with 17α-hydroxylase deficiency can present with short stature because they have no pubertal growth spurt during adolescence. Therefore, 17 OHD should be considered in the differential diagnosis of patients with delayed puberty and short stature.

PDF

___

1.Krone N,Arlt W. Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009; 23: 181-192.

2.Oh YK, Ryoo U, Kim D, et al. 17alpha-hydroxlyase/17, 20-lyase deficiency in three siblings with primary amenorrhea and absence of secondary sexual development. J Pediatr Adolesc Gynecol 2012; 25: e103-e105.

3.Costa-Santos M, Kater CE, Dias EP, Auchus RJ. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells. J Clin Endocrinol Metab 2004; 89: 43-48.

4.Biason-Lauber A, Boscaro M, Mantero F, Balercia G. Defects of steroidogenesis. J Endocrinol Invest 2010; 33: 756-766.

5.Biglieri EG. Mechanisms establishing the mineralocorticoid hormone pattern in the 17-hydroxylase deficiency syndrome. J Steroid Biochem 1979; 11(1B): 653-657.

6.Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 2001; 30: 101-119.

7.Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol 2017; 165(Pt A): 71-78.

8.Kota SK, Modi K, Jha R, Mandal SN. 17-α-hydroxylase deficiency: an unusual case with primary amenorrhea and hypertension. Indian J Endocrinol Metab 2011; 15: 127-129.

9.Britten FL, Ulett KB, Duncan EL, Perry-Keene DA. Primary amenorrhoea with hypertension: undiagnosed 17-α-hydroxylase deficiency. Med J Aust 2013; 199: 556-558.

10.Kim SM, Rhee JH. A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med 2015; 42: 72-76.

11.Biason-Lauber A, Boscaro M, Mantero F, Balercia G. Defects of steroidogenesis. J Endocrinol Invest 2010; 33: 756-766.

12.Dhir V, Reisch N, Bleicken CM, et al. Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene. J Clin Endocrinol Metab 2009; 94: 3058-3064.

13.Ma L, Peng F, Yu L, et al. Combined 17α-hydroxylase/17,20-lyase deficiency with short stature: case study. Gynecol Endocrinol 2016; 32: 264-266.

14.Juul A. The effects of oestrogens on linear bone growth. Hum Reprod Update 2001; 7: 303-313.

15.Kerrigan JR, Rogol AD. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev 1992; 13: 281-298.

16.Kardelen AD, Toksoy G, Baş F, et al. A rare cause of congenital adrenal hyperplasia: clinical and genetic findings and follow-up characteristics of six patients with 17-hydroxylase deficiency including two novel mutations. J Clin Res Pediatr Endocrinol 2018; 10: 206-215.

17.Soliman A, De Sanctis V, Elalaily R, Bedair S. Advances in pubertal growth and factors influencing it: can we increase pubertal growth? Indian J Endocrinol Metab 2014; 18(Suppl 1): S53-S62.

18.Gourmelen M, Pham-Huu-Trung MT, Girard F. Transient partial hGH deficiency in prepubertal children with delay of growth. Pediatr Res 1979; 13: 221-224.

19.Longobardi S, Merola B, Pivonello R, et al. Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. J Clin Endocrinol Metab 1996; 81: 1244-1247.